The authors made use of the 3D CoSeedis™ system to assess radiation resistance in 3D conditions via a colony forming assay (CFA).
A new publication on the colony forming assay in cancer research is available.
The sales team of BioConcept, our partner in Switzerland, visited us and attended a training day about 3D CoSeedis™.
The talk about the unique microenvironments in 3D models has been a great success.
Our product family is growing.
The symposium was a complete success.
Visit the symposium in Munich on 27 March 2019.
abc biopply is looking forward to working together with BioConcept on the success of 3D CoSeedis™.
Visit us on 5 February 2019 in France and learn more about 3D CoSeedis™.
3D CoSeedis™ has recently been used in a study on extracellular vesicle composition.
3D CoSeedis™ is now available in Germany, Austria, France and Canada.
A new publication about 3D CoSeedis™ is available.
abc biopply has developed a standardised way to conveniently embed 3D cell aggregates grown in the 3D CoSeedis™ matrix in paraffin for immunological analysis. In this context we haverecently also started a partnership with AnaPath.
abc biopply is introducing a fully standardised 3D micro-tumour system based on its 3D CoSeedis™ technology platform.
abc biopply launches a new 3D CoSeedis™ system in June.
Visit us at our booth E2 at the DECHEMA 3D Cell Culture Congress in Freiburg (DE)
Learn more about 3D CoSeedis™ and ask the experts directly.
We have received attention in various newspapers.
